drugset / Trial / NCT05805683

Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury

NCT05805683

Recruiting 126 enrolled Tanta University
RandomizedParallel-groupTriple-blindPrevention

Summary

This prospective randomized double blinded study will be conducted to evaluate the effect of early pharmacologic intervention with calcitonin on the incidence or the severity of neuropathic pain after spinal cord injury

Timeline

Start
2023-05-01
Primary completion
2027-05-01
Completion
2028-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcitonin Protein / enzyme biologic 100 iu Subcutaneous